Morgane Rousselet

676 total citations
36 papers, 379 citations indexed

About

Morgane Rousselet is a scholar working on Clinical Psychology, Toxicology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Morgane Rousselet has authored 36 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Clinical Psychology, 9 papers in Toxicology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Morgane Rousselet's work include Eating Disorders and Behaviors (7 papers), Opioid Use Disorder Treatment (6 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Morgane Rousselet is often cited by papers focused on Eating Disorders and Behaviors (7 papers), Opioid Use Disorder Treatment (6 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Morgane Rousselet collaborates with scholars based in France and United States. Morgane Rousselet's co-authors include Marie Grall‐Bronnec, Caroline Victorri‐Vigneau, Pascale Jolliet, Gaëlle Challet‐Bouju, Marie Gérardin, Marylène Guerlais, Juliette Leboucher, Pascal Derkinderen, Jean-Benoît Hardouin and Pascal Caillet and has published in prestigious journals such as PLoS ONE, Nutrients and Clinical Pharmacology & Therapeutics.

In The Last Decade

Morgane Rousselet

30 papers receiving 369 citations

Peers

Morgane Rousselet
S Pirzada Sattar United States
Joan M. Anzia United States
Raj K. Kalapatapu United States
Zeeshan Mansuri United States
Samuel L. Battalio United States
S Pirzada Sattar United States
Morgane Rousselet
Citations per year, relative to Morgane Rousselet Morgane Rousselet (= 1×) peers S Pirzada Sattar

Countries citing papers authored by Morgane Rousselet

Since Specialization
Citations

This map shows the geographic impact of Morgane Rousselet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgane Rousselet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgane Rousselet more than expected).

Fields of papers citing papers by Morgane Rousselet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgane Rousselet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgane Rousselet. The network helps show where Morgane Rousselet may publish in the future.

Co-authorship network of co-authors of Morgane Rousselet

This figure shows the co-authorship network connecting the top 25 collaborators of Morgane Rousselet. A scholar is included among the top collaborators of Morgane Rousselet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgane Rousselet. Morgane Rousselet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rousselet, Morgane, et al.. (2025). Enhancing addiction care: Benefits of urinary screening with LC-HRMS (liquid chromatography-high resolution mass spectrometry) for psychoactive substances and drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 141. 111465–111465.
2.
Rousselet, Morgane, et al.. (2024). Physicians, pharmacists and take-home naloxone: What practices? The SINFONI study. Therapies. 79(6). 623–633.
3.
Rousselet, Morgane, et al.. (2024). “Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose. Harm Reduction Journal. 21(1). 20–20. 1 indexed citations
4.
Rousselet, Morgane, et al.. (2024). Cannabis use and dependence among festival attendees: results from the French OCTOPUS survey. BMC Public Health. 24(1). 992–992.
5.
6.
Vanier, Antoine, et al.. (2023). Is history of abuse predictive of eating disorders with binge-eating episodes through an effect mediated by impulsivity? A French longitudinal study. Journal of Psychiatry and Neuroscience. 48(1). E13–E22. 2 indexed citations
7.
Gérardin, Marie, Morgane Rousselet, A. Masseau, et al.. (2021). Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study. PLoS ONE. 16(3). e0248649–e0248649. 3 indexed citations
8.
Fauconnier, Marie‐Laure, Morgane Rousselet, Paul Brunault, et al.. (2020). Food Addiction among Female Patients Seeking Treatment for an Eating Disorder: Prevalence and Associated Factors. Nutrients. 12(6). 1897–1897. 36 indexed citations
9.
Rousselet, Morgane, et al.. (2020). Evaluation of cognitive impairment in a French sample of patients with restrictive anorexia nervosa: two distinct profiles emerged with differences in impaired functions and psychopathological symptoms. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 26(5). 1559–1570. 2 indexed citations
10.
Caillet, Pascal, Morgane Rousselet, Marie Gérardin, Pascale Jolliet, & Caroline Victorri‐Vigneau. (2020). Prevalence of zolpidem use in France halved after secure prescription pads implementation in 2017: A SNDS database nested cohort study. PLoS ONE. 15(2). e0228495–e0228495. 11 indexed citations
11.
Rousselet, Morgane, Fanny Feuillet, Olivier Bonnot, et al.. (2019). The MEOPAeDent trial protocol—an observational study of the Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) effects in paediatric dentistry. BMC Oral Health. 19(1). 42–42. 2 indexed citations
12.
Bulteau, Samuel, et al.. (2019). Assessment of an Equimolar Mixture of Oxygen and Nitrous Oxide: Effects in Pediatric Dentistry. International Journal of Clinical Pediatric Dentistry. 12(5). 429–436. 9 indexed citations
13.
Gérardin, Marie, Morgane Rousselet, Pascal Caillet, et al.. (2019). French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol. BMJ Open. 9(6). e027443–e027443. 14 indexed citations
14.
15.
Rousselet, Morgane, et al.. (2017). Cult membership: What factors contribute to joining or leaving?. Psychiatry Research. 257. 27–33. 16 indexed citations
16.
Grall‐Bronnec, Marie, Caroline Victorri‐Vigneau, Juliette Leboucher, et al.. (2017). Dopamine Agonists and Impulse Control Disorders: A Complex Association. Drug Safety. 41(1). 19–75. 104 indexed citations
17.
Rousselet, Morgane, Fanny Feuillet, Marie Gérardin, et al.. (2017). The French addictovigilance network clinical assessment: Z-drugs, true false twins. Expert Opinion on Drug Safety. 16(9). 1063–1069. 15 indexed citations
18.
Rousselet, Morgane, et al.. (2016). Disordered eating in French high-level athletes: association with type of sport, doping behavior, and psychological features. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 22(1). 61–68. 31 indexed citations
19.
20.
Victorri‐Vigneau, Caroline, Marie Gérardin, Morgane Rousselet, et al.. (2014). An Update on Zolpidem Abuse and Dependence. Journal of Addictive Diseases. 33(1). 15–23. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026